Stefani Wolff - 16 Aug 2021 Form 3 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
EVP and COO
Signature
/s/ Christine Ring, as Attorney-in-Fact for Stefani Wolff
Issuer symbol
NRIX
Transactions as of
16 Aug 2021
Net transactions value
$0
Form type
3
Filing time
17 Aug 2021, 17:19:26 UTC
Previous filing
18 May 2021
Next filing
21 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NRIX Employee Stock Option (right to buy) 16 Aug 2021 Common Stock 443,865 $23.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/4 of the total shares on August 16, 2022, and 1/48 of the total shares vests monthly thereafter until the option is fully vested on August 16, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.